Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-014861
Filing Date
2017-02-27
Accepted
2017-02-27 17:05:15
Documents
1
Period of Report
2017-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4735
  Complete submission text file 0001209191-17-014861.txt   7359
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address
TANG KEVIN C (Reporting) CIK: 0001178579 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 17642879

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Reporting) CIK: 0001191935 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 17642877

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Reporting) CIK: 0001232621 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 17642878